The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Consulting or Advisory Role - AstraZeneca; GlaxoSmithKline
 
Consulting or Advisory Role - AstraZeneca; Roche; Sotio
Olaparib maintenance monotherapy for non-germline BRCA1/2-mutated (non-gBRCAm) platinum-sensitive relapsed ovarian cancer (PSR OC) patients (pts): Phase IIIb OPINION interim analysis.
 
Andres Poveda
Consulting or Advisory Role - AstraZeneca; Clovis Oncology; PharmaMar; Roche; Tesaro
Travel, Accommodations, Expenses - PharmaMar
 
Stephanie Lheureux
Honoraria - AstraZeneca
Consulting or Advisory Role - AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca; GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline; Merck; Roche/Genentech
Research Funding - AstraZeneca (Inst); Merck (Inst); Regeneron (Inst); Roche/Genentech (Inst); Tesaro (Inst)
 
Nicoletta Colombo
Honoraria - AstraZeneca; PharmaMar; Roche/Genentech; Tesaro
Consulting or Advisory Role - AstraZeneca; BioCad; Clovis Oncology; GlaxoSmithKline; MSD Oncology; Pfizer; PharmaMar; Roche/Genentech; Takeda; Tesaro
 
David Cibula
No Relationships to Disclose
 
Kristina Lindemann
No Relationships to Disclose
 
Johanne I Weberpals
Consulting or Advisory Role - AstraZeneca
 
Maria Bjurberg
No Relationships to Disclose
 
Ana Oaknin
Consulting or Advisory Role - AstraZeneca; Clovis Oncology; Genmab; Immunogen; PharmaMar; Roche; Tesaro
Research Funding - Abbvie (Inst); Ability Pharma (Inst); Advaxis (Inst); Aeterna Zentaris (Inst); Amgen (Inst); Amgen (Inst); Aprea Therapeutics (Inst); Clovis Oncology (Inst); Eisai (Inst); Regeneron (Inst); Roche (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Clovis Oncology; PharmaMar; Roche
 
Magdalena Sikorska
Speakers' Bureau - AstraZeneca; Roche
Research Funding - AstraZeneca; Clovis Oncology; Pfizer; Tesaro
Travel, Accommodations, Expenses - AstraZeneca; Roche
 
Antonio Gonzalez Martin
Consulting or Advisory Role - Amgen; AstraZeneca; Clovis Oncology; Genmab; GlaxoSmithKline/Tesaro; ImmunoGen; Merck; MSD; Novartis; Oncoinvent; Pfizer; Roche
Speakers' Bureau - AstraZeneca; GlaxoSmithKline/Tesaro; PharmaMar; Roche
Research Funding - GlaxoSmithKline/Tesaro; Roche
Travel, Accommodations, Expenses - AstraZeneca; GlaxoSmithKline/Tesaro
 
Radoslaw Madry
Consulting or Advisory Role - AstraZeneca; GlaxoSmithKline
Speakers' Bureau - AstraZeneca; GlaxoSmithKline; Roche
Travel, Accommodations, Expenses - AstraZeneca; Roche
 
Maria Jesus Rubio Pérez
No Relationships to Disclose
 
Richard Davidson
Employment - AstraZeneca
Stock and Other Ownership Interests - AstraZeneca
 
Christopher Blakeley
Employment - AstraZeneca; Worldwide Clinical Trials
Stock and Other Ownership Interests - Pfizer
 
James Bennett
Employment - AstraZeneca
 
Alan Barnicle
Employment - AstraZeneca
Stock and Other Ownership Interests - AstraZeneca
 
Erik Skof
No Relationships to Disclose